Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
The Journal of Infection|July 4, 2020
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?Marie Gousseff, Pauline Penot, Laure Gallay, et al.Blood Advances|August 5, 2025
Safety and Efficacy of Daratumumab in Immune ThrombocytopeniaGalina Tsykunova, Pål Andre Holme, Hoa Thi Thyuet Tran, et al.The Journal of Clinical Investigation|May 3, 2022
High-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpuraPablo Canales-Herrerias, Etienne Crickx, Matteo Broketa, et al.Blood Advances|January 28, 2025
Efficacy and safety of dapsone in adult primary immune thrombocytopeniaMarion Larue, Guillaume Moulis, Manuela Rueter, et al.American Journal of Hematology|January 8, 2026
Incidence, Characteristics, and Management of Venous Thrombosis in Adult Patients With Immune Thrombocytopenia: Results From the Multicenter, Prospective Registry CARMEN-FranceFrançois Therme, Jean Francois Viallard, Manuela Rueter, et al.Blood|October 27, 2012
A case-control study to assess the risk of immune thrombocytopenia associated with vaccinesLamiae Grimaldi-Bensouda, Marc Michel, Elodie Aubrun, et al.JAMA Dermatology|June 1, 2017
Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 CasesValentine Heidelberger, Saskia Ingen-Housz-Oro, Alicia Marquet, et al.Journal of Autoimmunity|November 2, 2022
Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung diseasePierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, et al.Blood|September 22, 2020
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19Thomas Hueso, Cécile Pouderoux, Hélène Péré, et al.Blood|October 30, 2024
Long-term follow-up of the STOPAGO studyAdrien Cottu, Stéphanie Guillet, Jean-François Viallard, et al.Pageof 4